GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (OTCPK:CGNSF) » Definitions » Piotroski F-Score

Cognetivity Neurosciences (Cognetivity Neurosciences) Piotroski F-Score : 4 (As of May. 26, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Cognetivity Neurosciences has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Cognetivity Neurosciences's Piotroski F-Score or its related term are showing as below:

CGNSF' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 3   Max: 5
Current: 4

During the past 7 years, the highest Piotroski F-Score of Cognetivity Neurosciences was 5. The lowest was 1. And the median was 3.


Cognetivity Neurosciences Piotroski F-Score Historical Data

The historical data trend for Cognetivity Neurosciences's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Piotroski F-Score Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Piotroski F-Score
Get a 7-Day Free Trial 3.00 2.00 3.00 2.00 5.00

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 5.00 4.00 N/A 4.00

Competitive Comparison of Cognetivity Neurosciences's Piotroski F-Score

For the Health Information Services subindustry, Cognetivity Neurosciences's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cognetivity Neurosciences's Piotroski F-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Oct23) TTM:Last Year (Oct22) TTM:
Net Income was -1.91 + -1.563 + -1.465 + -1.486 = $-6.42 Mil.
Cash Flow from Operations was -1.25 + -1.131 + -0.506 + 0.012 = $-2.88 Mil.
Revenue was 0.034 + 0.003 + 0.015 + 0.021 = $0.07 Mil.
Gross Profit was 0.034 + 0.003 + 0.015 + 0.021 = $0.07 Mil.
Average Total Assets from the begining of this year (Oct22)
to the end of this year (Oct23) was
(3.687 + 2.108 + 0.976 + 0.416 + 0.355) / 5 = $1.5084 Mil.
Total Assets at the begining of this year (Oct22) was $3.69 Mil.
Long-Term Debt & Capital Lease Obligation was $1.00 Mil.
Total Current Assets was $0.22 Mil.
Total Current Liabilities was $11.44 Mil.
Net Income was -4.112 + -1.176 + -1.228 + -1.312 = $-7.83 Mil.

Revenue was 0 + 0 + 0 + 0 = $0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = $0.00 Mil.
Average Total Assets from the begining of last year (Oct21)
to the end of last year (Oct22) was
(0.893 + 1.588 + 0.774 + 0 + 3.687) / 5 = $1.7355 Mil.
Total Assets at the begining of last year (Oct21) was $0.89 Mil.
Long-Term Debt & Capital Lease Obligation was $0.91 Mil.
Total Current Assets was $3.55 Mil.
Total Current Liabilities was $3.44 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Cognetivity Neurosciences's current Net Income (TTM) was -6.42. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Cognetivity Neurosciences's current Cash Flow from Operations (TTM) was -2.88. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Oct22)
=-6.424/3.687
=-1.74233794

ROA (Last Year)=Net Income/Total Assets (Oct21)
=-7.828/0.893
=-8.76595745

Cognetivity Neurosciences's return on assets of this year was -1.74233794. Cognetivity Neurosciences's return on assets of last year was -8.76595745. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Cognetivity Neurosciences's current Net Income (TTM) was -6.42. Cognetivity Neurosciences's current Cash Flow from Operations (TTM) was -2.88. ==> -2.88 > -6.42 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Oct23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Oct22 to Oct23
=0.998/1.5084
=0.66162822

Gearing (Last Year: Oct22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Oct21 to Oct22
=0.907/1.7355
=0.52261596

Cognetivity Neurosciences's gearing of this year was 0.66162822. Cognetivity Neurosciences's gearing of last year was 0.52261596. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Oct23)=Total Current Assets/Total Current Liabilities
=0.221/11.437
=0.01932325

Current Ratio (Last Year: Oct22)=Total Current Assets/Total Current Liabilities
=3.547/3.439
=1.03140448

Cognetivity Neurosciences's current ratio of this year was 0.01932325. Cognetivity Neurosciences's current ratio of last year was 1.03140448. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Cognetivity Neurosciences's number of shares in issue this year was 88.369. Cognetivity Neurosciences's number of shares in issue last year was 79.403. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.073/0.073
=1

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0/0
=

Cognetivity Neurosciences's gross margin of this year was 1. Cognetivity Neurosciences's gross margin of last year was . ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Oct22)
=0.073/3.687
=0.01979929

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Oct21)
=0/0.893
=0

Cognetivity Neurosciences's asset turnover of this year was 0.01979929. Cognetivity Neurosciences's asset turnover of last year was 0. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+0+0+0+1+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Cognetivity Neurosciences has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Cognetivity Neurosciences  (OTCPK:CGNSF) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Cognetivity Neurosciences Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences (Cognetivity Neurosciences) Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (Cognetivity Neurosciences) Headlines

From GuruFocus

The Most Innovative Healthcare AI Developments of 2019

By ACCESSWIRE AccessWire 04-12-2019